
Number of publications published per year by Charlton, Michael R.. (Source : PubMed)

Distribution of publications types for Charlton, Michael R.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.
J. Hepatol.
2010;52;4
Antibody-Based Immunosuppression Following Liver Transplantation: The Plot Thickens.
Am. J. Transplant.
2010

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.
Liver Transpl.
2009;15;11
Combined heart and liver transplantation: a single-center experience.
Transplantation
2009;88;2
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
Am. J. Transplant.
2009;9;6
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
Am. J. Transplant.
2008;8;11

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Clin. Gastroenterol. Hepatol.
2007;5;3


Impact of obesity on treatment of chronic hepatitis C.
Hepatology
2006;43;6


Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
Liver Transpl.
2005;11;10

Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Am. J. Gastroenterol.
2005;100;4
[ See timeline ] [ See all publications ]
means that Charlton, Michael R. has 19 papers cited a least 19 times - methodology
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.